# OnCo record idp-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/idp-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "idp-001" ;
  schema:name "IDP-001"@en ;
  schema:description "IDP-001 is an experimental bispecific antibody-drug conjugate from InduPro Therapeutics, in phase 1 trials for non-small cell lung cancer, head and neck squamous cell carcinoma and cutaneous squamous cell carcinoma and other cancers."@en ;
  schema:url <https://onco.cc/drugs/idp-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.induprotx.com/pipeline>, <https://www.induprotx.com/news/indupro-closes-77-million-series-b-financing-and-doses-first-patient-in-phase-1-study-of-lead-oncology-program-idp-001/>, <https://clinicaltrials.gov/api/v2/studies/NCT07602842>, <https://clinicaltrials.gov/search?intr=IDP-001> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/oesophageal-squamous-cell-carcinoma/>, <https://onco.cc/cancers/anal/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:companies <https://onco.cc/companies/indupro-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07602842/> .